Active Ingredient
Docusate Sodium 50mg
Sennosides 8.6 mg
The following Structured Product Label (SPL) was submitted to the FDA by Mckesson Packaging Services A Business Unit Of Mckesson Corporation for the product Sennosides And Docusate Sodium (NDC 63739-432). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docusate Sodium 50mg
Sennosides 8.6 mg
Docusate Sodium...............Stool Softener
Sennosides.........................Stimulant Laxative
| Age | Starting Dose | Maximum Dose |
| Adults and children 12 years of age and older | 2 tablets once a day | 4 tablets twice a day |
| Children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| Children 2 to under 6 years | 1/2 tablet once a day | 1 tablets twice a day |
| Children under 2 years | ask a doctor | ask a doctor |
carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide, **tapioca starch, **tartaric acid
** may contain one or more of these ingredients
* Please review the disclaimer below.